Clinical Trial

Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial

Study acronym: ENHANCE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the feasibility and effects of 12-week exercise training at different intensities among individuals with advanced lung cancer receiving immune checkpoint inhibitors. The names of the study interventions involved in this study are: * High-intensity interval training (HIIT) * Moderate-intensity continuous training (MICT) * Usual care (UC)
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-31 -> 2027-12-31 2026-08-11
minor Completion pushed: 2027-12-31 -> 2028-12-31 2026-08-11
Trial Details
NCT Number NCT06026111
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI)
Conditions Lung Cancer
Enrollment 30 participants
Start Date 2024-02-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10